Momenta Pharma
(MNTA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2014 | 12-2013 | 09-2013 | 06-2013 | 03-2013 | |
| Sales | 10,785 | 12,750 | 10,751 | 4,361 | 7,603 |
| Gross Profit | 10,785 | 12,750 | 10,751 | 4,361 | 7,603 |
| Operating Expenses | 38,409 | 43,086 | 36,412 | 33,510 | 32,048 |
| Operating Income | -27,624 | -30,336 | -25,661 | -29,149 | -24,445 |
| Other Income | 262 | 274 | 279 | 301 | 329 |
| Pre-tax Income | -27,362 | -30,062 | -25,382 | -28,848 | -24,116 |
| Net Income Continuous | -27,362 | -30,062 | -25,382 | -28,848 | -24,116 |
| Net Income | $-27,362 | $-30,062 | $-25,382 | $-28,848 | $-24,116 |
| EPS Basic Total Ops | -0.53 | -0.58 | -0.50 | -0.57 | -0.48 |
| EPS Basic Continuous Ops | -0.53 | -0.59 | -0.50 | -0.57 | -0.48 |
| EPS Diluted Total Ops | -0.53 | -0.58 | -0.50 | -0.57 | -0.48 |
| EPS Diluted Continuous Ops | -0.53 | -0.59 | -0.50 | -0.57 | -0.48 |
| EBITDA(a) | $-24,649 | $-26,560 | $-23,557 | $-26,181 | $-21,549 |